Status:

NOT_YET_RECRUITING

Using Red Light Therapy to Ease Skin Side Effects and Mouth Side Effects, in Children and Young People Aged 0 to 16 Years Old, Receiving Radiotherapy

Lead Sponsor:

The Christie NHS Foundation Trust

Conditions:

Radio Dermatitis

Mucositis Oral

Eligibility:

All Genders

Up to 16 years

Phase:

NA

Brief Summary

The goal of this interventional study is to see if the daily use of red light therapy called photobiomodulation can help sore skin and sore mouths in children having radiotherapy. All children aged 0...

Eligibility Criteria

Inclusion

  • Paediatric patient receiving a treatment course of either proton or photon therapy - Craniospinal treatment field, Head and Neck treatment fields and body treatment fields.

Exclusion

  • Paediatric patients receiving focal brain only proton or photon radiotherapy.
  • Paediatric patients receiving a single fraction of proton or photon therapy.
  • Total Body Irradiation patients.

Key Trial Info

Start Date :

October 1 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

April 1 2028

Estimated Enrollment :

248 Patients enrolled

Trial Details

Trial ID

NCT07183267

Start Date

October 1 2025

End Date

April 1 2028

Last Update

September 19 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

The Christie NHS Foundation Trust

Manchester, Cheshire, United Kingdom, M20 4BX